Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells

Published:2015-06-04 Issue:5 Volume:55 Page:991-1001
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Lee Yongik¹,Wang Yian¹,James Michael²,Jeong Joseph H.³,You Ming¹⁴

Affiliation:

1. Department of Pharmacology & Toxicology; Medical College of Wisconsin; Milwaukee Wisconsin

2. Department of Surgery; Medical College of Wisconsin; Milwaukee Wisconsin

3. Department of Dermatology; Medical College of Wisconsin; Milwaukee Wisconsin

4. Cancer Center; Medical College of Wisconsin; Milwaukee Wisconsin

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mc.22342/fullpdf

Reference48 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

3. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

4. SnapShot: EGFR signaling pathway;Yarden;Cell,2007

5. Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin;Okamoto;Mol Cancer Ther,2012

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression;Cancer Science;2024-06-28

2. Single cell lineage tracing reveals clonal dynamics of anti-EGFR therapy resistance in triple negative breast cancer;Genome Medicine;2024-04-11

3. Role of Insulin-like Growth Factor-1 Receptor in Tobacco Smoking-Associated Lung Cancer Development;Biomedicines;2024-03-02

4. Development of covalent inhibitors: Principle, design, and application in cancer;MedComm – Oncology;2023-10-31

5. Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators;Cancers;2023-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3